1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Equillium Acquires Metacrine

M&A Deal Summary

Equillium Acquires Metacrine

On September 6, 2022, Equillium acquired life science company Metacrine

Acquisition Highlights
  • This is Equillium’s 2nd transaction in the Life Science sector.
  • This is Equillium’s 2nd transaction in the United States.
  • This is Equillium’s 2nd transaction in California.

M&A Deal Summary
Date 2022-09-06
Target Metacrine
Sector Life Science
Buyer(s) Equillium
Deal Type Add-on Acquisition

Target

Metacrine

San Diego, California, United States
Metacrine is a clinical-stage biopharmaceutical company building a pipeline of differentiated therapies to treat gastrointestinal and liver diseases. Metacrine has developed a proprietary farnesoid X receptor (FXR) platform utilizing a unique chemical scaffold, which has demonstrated an improved therapeutic profile in clinical trials. Metacrine is based in San Diego, California.

Search 214,877 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Equillium

La Jolla, California, United States
Category Company
Founded 2017
Sector Life Science
Employees35
Revenue 41M USD (2024)
DESCRIPTION

Equillium is a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel products to treat severe autoimmune and inflammatory disorders with high unmet medical needs. Equillium was founded in 2017 and is based in La Jolla, California.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 2 of 2
State: California M&A 2 of 2
Country: United States M&A 2 of 2
Year: 2022 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-02-16 Bioniz Therapeutics

Irvine, California, United States

Bioniz Therapeutics is a clinical-stage biopharmaceutical company developing precision cytokine targeted therapies for the treatment of immuno-inflammatory diseases. Bioniz Therapeutics was founded in 2010 and is based in Irvine, California.

Buy -
Mergr

Solution for

Product

Company

Legal